Pulse Biosciences, Inc.
PLSE
株式のランク
#4258
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric... Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
株価
$51.39
最終同期: 2026-10-21
時価総額
$3.67B
変化（1日）
1.09%
変化（1年）
197.94%
国
US
取引 Pulse Biosciences, Inc. (PLSE)
カテゴリー
Healthcare
Pulse Biosciences, Inc.（PLSE）の株価履歴
終値の最高値: $49.20 （2026-10-01）
終値の最安値: $4.20 （2016-05-01）
終値の最安値: $4.20 （2016-05-01）
Pulse Biosciences, Inc. の株価履歴（2016 ～ 2026）
年間株価パフォーマンス
| 年 | パフォーマンス |
|---|---|
| 2026 (TTM) | 90.82% |
| 2025 | -23.80% |
| 2024 | 72.60% |
| 2023 | 322.28% |
| 2022 | -84.88% |
| 2021 | -15.48% |
| 2020 | 41.40% |
| 2019 | 19.04% |
| 2018 | -50.17% |
| 2017 | 306.74% |
| 2016 | 0.00% |
類似企業または競合の株価
| 企業 | 株価 | 変化率 1年% | 国 |
|---|---|---|---|
| $431.34 | -18.16% |
US
|
|
| $196.36 | -45.70% |
FR
|
|
| $170.48 | 12.48% |
JP
|
|
| $194.26 | 31.35% |
US
|
|
| $68.05 | -11.08% |
CH
|
